Klingman & Associates’s Cognizant CTSH Stock Holding History

Klingman & Associates’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,895	Closed	-$212K	–	251
2024 Q1	$212K	Buy	+2,895	New	+$221K	0.01%	226

Other funds holding CTSH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Klingman & Associates's CTSH Position: Q2 2024 in Review

Klingman & Associates sold out of Cognizant (CTSH) in Q2 2024, closing a stake of 2,895 shares — an estimated $212K sold.

Klingman & Associates first reported a position in CTSH in Q1 2024 and held it in 1 quarter. The position peaked at $212K in Q1 2024. 902 funds tracked by Wall St. Rank hold CTSH as of Q2 2024.

Klingman & Associates reported no remaining Cognizant position as of Q2 2024 after selling out during the quarter.
Klingman & Associates sold 2,895 Cognizant shares in Q2 2024, an estimated $212K.
Klingman & Associates first reported a position in Cognizant in Q1 2024 and held it in 1 quarter.
Klingman & Associates's Cognizant position peaked at $212K in Q1 2024.
902 funds tracked by Wall St. Rank held Cognizant as of Q2 2024.

Based on Klingman & Associates's 13F filing for Q2 2024, filed 30 Jul 2024.